Lenalidomide for Advanced Hepatocellular Cancer:A Phase II Trial
Phase of Trial: Phase II
Latest Information Update: 23 Mar 2015
At a glance
- Drugs Lenalidomide (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 20 Feb 2014 According to the ClinicalTrials.gov record, status changed from active, no longer recruiting to completed.
- 20 Nov 2012 Planned end date changed from 1 Dec 2012 to 1 Jun 2013 as reported by ClinicalTrials.gov.
- 23 Jan 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.